Market Cap | ₹62Cr |
ROE | 0.99% |
P/E Ratio(TTM) | 144.14 |
EPS(TTM) | 0.43 |
P/B Ratio | 1.82 |
Dividend Yield | 0.00% |
Industry P/E | 35.31 |
Book Value | 34.11 |
Debt to Equity | 0.50 |
Face Value | 10 |
Parent Organisation | Concord Drugs Limited |
Managing Director | Mr. Seelam Reddy |
BSE Symbol | 538965 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 104.62 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.68 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.29 | ||
Wockhardt | NA (0.00%) | -149.63 |